Table 1.
Donor | SV5 | MuV | HPIV2 |
---|---|---|---|
1 | 5.1 (3.0) | 5.3 | 6.3 (3.3) |
2 | 4.7 (2.9) | 5.0 | 6.0 (3.0) |
3 | 5.4 (2.9) | 5.2 | 6.2 (3.3) |
4 | 4.9 | 5.0 | 5.8 |
5 | 5.4 (2.9) | 5.3 | 6.0 (3.9) |
6 | 5.1 (1.0) | 5.0 | 6.4 (1.2) |
7 | 4.7 | 5.0 | 5.3 |
8 | 4.6 | 5.0 | 5.5 |
9 | 5.6 | 5.6 | 6.3 |
10 | 4.7 | 4.6 | 6.1 |
Mean titer | 5.1 | 5.2 | 6.1 |
Elisa plates were coated with purified SV5, MuV or HPIV2 virions, and then incubated with dilutions of serum for each donor, followed by HRP-conjugated secondary goat anti-human IgG.
Data are expressed as the log10 of the dilution of serum that yielded an absorbance of two times that obtained with controls using secondary antibody only. Values in parentheses represent the ratio of IgG1 to IgG2 titers.